Association between elevated liver enzymes and metabolic syndrome among Thai adults

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 2, Issue 3, 2008, Pages 171-178

  Perera, Sajithya ^a   Lohsoonthorn, Vitool ^a,b   Jiamjarasrangsi, Wiroj ^b   Lertmaharit, Somrat ^b   Williams, Michelle A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Epidemiology; Liver enzymes; Metabolic syndrome; Risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER ENZYME; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; THAILAND; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 47649105635     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2008.04.012     Document Type: Article

References (30)

1. CEP. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 19 (2001) 2486-2487
2. Kolovou G.D., Anagnostopoulou K.K., Salpea K.D., and Mikhailidis D.P. The prevalence of metabolic syndrome in various populations. Am J Med Sci 333 6 (2007) 362-371
3. Nakanishi N., Takatorige T., Fukuda H., Shirai K., Li W., Okamoto M., et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 64 1 (2004) 59-70
4. Patel A., Barzi F., Woodard M., Ni Mhurchu C., Ohkubo T., Lam T.H., et al. An evaluation of metabolic risks for coronary death in the Asia Pacific region. Diabetes Res Clin Pract 74 3 (2006) 274-281
5. Ko G.T., Cockram C.S., Chow C.C., Yeung V.T., Chan W.B., So W.Y., et al. Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Res Clin Pract 73 1 (2006) 58-64
6. Oh S.Y., Cho Y.K., Kang M.S., Yoo T.W., Park J.H., Kim H.J., et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 55 12 (2006) 1604-1609
7. Haffner S.M. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. Am J Med 119 5 Suppl. 1 (2006) S3-9
8. Marchesini G., Marzocchi R., Agostini F., and Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 16 4 (2005) 421-427
9. Chitturi S., Farrell G.C., and George J. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?. J Gastroenterol Hepatol 19 4 (2004) 368-374
10. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 4 (2003) 917-923
11. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino Jr. R.B., and Haffner S.M. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54 11 (2005) 3140-3147
12. Sattar N., Scherbakova O., Ford I., O'Reilly D.S., Stanley A., Forrest E., et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 53 11 (2004) 2855-2860
13. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 4 (2004) 380-385
14. Nakanishi N., Suzuki K., and Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27 6 (2004) 1427-1432
15. Hasan I., Gani R., and Machmud R. Prevalence and risk factors for nonalcoholic fatty liver in Indonesia. J Gastroenterol Hepatol 17 Suppl. (2002) A30
16. Lin J.D., Chiou W.K., Weng H.F., Fang J.T., and Liu T.H. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome. Clin Nutr 23 6 (2004) 1313-1323
17. Kim E.S., Han S.M., Kim Y.I., Song K.H., Kim M.S., Kim W.B., et al. Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea. Diabet Med 21 10 (2004) 1141-1143
18. Gu D., Reynolds K., Wu X., Chen J., Duan X., Reynolds R.F., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 9468 (2005) 1398-1405
19. Wang J., Thornton J.C., Bari S., Williamson B., Gallagher D., Heymsfield S.B., et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 77 2 (2003) 379-384
20. Shiwaku K., Nogi A., Kitajima K., Anuurad E., Enkhmaa B., Yamasaki M., et al. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health 47 2 (2005) 126-135
21. Rothman K.J., and Greenland S. Modern epidemiology. 2nd ed. (1998), Lippincott-Raven, Philadelphia, PA
22. Patel D.A., Srinivasan S.R., Xu J.H., Chen W., and Berenson G.S. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism. 56 6 (2007) 792-798
23. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98 5 (2003) 960-967
24. Pongchaiyakul C., Nguyen T.V., Wanothayaroj E., Karusan N., and Klungboonkrong V. Prevalence of metabolic syndrome and its relationship to weight in the Thai population. J Med Assoc Thai 90 3 (2007) 459-467
25. Lee W.Y., Park J.S., Noh S.Y., Rhee E.J., Kim S.W., and Zimmet P.Z. Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 65 2 (2004) 143-149
26. Wong V.W., Chan H.L., Hui A.Y., Chan K.F., Liew C.T., Chan F.K., et al. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese. Aliment Pharmacol Ther 20 1 (2004) 45-49
27. Malik A., Cheah P.L., Hilmi I.N., Chan S.P., and Goh K.L. Non-alcoholic fatty liver disease in Malaysia: a demographic, anthropometric, metabolic and histological study. J Dig Dis 8 1 (2007) 58-64
28. Tanomsup S., Aekplakorn W., Sritara P., Woodward M., Yamwong S., Tunlayadechanont S., et al. A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand. Diabetes Care 30 8 (2007) 2138-2140
29. Marchesini G., Avagnina S., Barantani E.G., Ciccarone A.M., Corica F., Dall'Aglio E., et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest 28 4 (2005) 333-339
30. Schindhelm R.K., Dekker J.M., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J., et al. Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabetes Med 24 4 (2007) 430-435